BioCentury | May 17, 2019
Financial News

Tools4Patient raises €4M to refine, expand placebo response analytics

...told BioCentury. Innovation Fund and Sambrinvest joined existing investors in the new round, including former Eurogentec S.A....
BioCentury | Feb 7, 2011
Company News

Eurogentec, ImaginAb deal

...The companies partnered to produce antibody fragments for ImaginAb using Eurogentec's Pichia pastoris expression system. ImaginAb...
...agents for the diagnosis and treatment of cancer and autoimmune diseases. Further terms not disclosed. Eurogentec S.A....
BioCentury | Nov 2, 2009
Company News

AnaSpec, Eurogentec deal

...Supply/Service company Eurogentec will acquire proteomics company AnaSpec for an undisclosed sum. AnaSpec's marketed products include...
...assays, SensoLyte assays for high throughput screening and drug discovery, and dye-labeled peptides for diagnostics. Eurogentec...
...includes Eurogentec's OliGold custom oligonucleotides. Achelous Partners LLC advised AnaSpec. AnaSpec Inc. , Fremont, Calif. Eurogentec S.A....
BioCentury | May 14, 2007
Company News

CytoGenix, Eurogentec deal

...CYGX and Eurogentec signed a letter of intent to develop undisclosed products using CYGX's synDNA production...
...influenza, HIV/AIDS, smallpox and HBV. Further terms were not disclosed. CytoGenix Inc. (CYGX), Houston, Texas Eurogentec S.A....
BioCentury | Jan 22, 2007
Company News

Eurogentec, Geymonat S.p.A., Roche, ThromboGenics N.V cardiovascular news

...granted E2 million ($2.6 million) to the Vasoplus research consortium, which consists of THR, Geymonat, Eurogentec...
...is a homolog of vascular endothelial growth factor (VEGF) and is currently in preclinical testing. Eurogentec S.A....
BioCentury | May 1, 2006
Company News

Eurogentec, Oxford Gene Technology Ltd. deal

...Oxford granted Eurogentec a license to Southern array patents, which cover the manufacture, use and marketing...
...which cover the manufacture, use and marketing of oligonucleotide microarrays. Further terms were not disclosed. Eurogentec S.A....
BioCentury | Jul 18, 2005
Company News

Alnylam, Eurogentec deal

...ALNY granted Eurogentec a non-exclusive license to its RNAi patents, for use in developing research products...
...and their use to mediate RNAi in mammalian cells. Alnylam Pharmaceuticals Inc. (ALNY), Cambridge, Mass. Eurogentec S.A....
BioCentury | Apr 11, 2005
Company News

Eurogentec, Proteo Biotech deal

...and proteinase 3. The compound has completed preclinical testing to treat tissue and muscle damage. Eurogentec S.A....
BioCentury | Dec 6, 2004
Company News

Eurogentec SA, SuperArray Bioscience Corp. sales and marketing update

...deal for its first-generation technology will let it focus on its next-generation Oligo GEArray technology. Eurogentec...
BioCentury | Jun 2, 2003
Company News

Epoch Biosciences, Eurogentec deal

...on its MGB Eclipse Probe System business. Also, the companies expanded a 2002 deal for Eurogentec...
...and Japan. As expanded, the deal includes North America. Epoch Biosciences Inc. (EBIO), Bothell, Wash Eurogentec S.A....
Items per page:
1 - 10 of 21
BioCentury | May 17, 2019
Financial News

Tools4Patient raises €4M to refine, expand placebo response analytics

...told BioCentury. Innovation Fund and Sambrinvest joined existing investors in the new round, including former Eurogentec S.A....
BioCentury | Feb 7, 2011
Company News

Eurogentec, ImaginAb deal

...The companies partnered to produce antibody fragments for ImaginAb using Eurogentec's Pichia pastoris expression system. ImaginAb...
...agents for the diagnosis and treatment of cancer and autoimmune diseases. Further terms not disclosed. Eurogentec S.A....
BioCentury | Nov 2, 2009
Company News

AnaSpec, Eurogentec deal

...Supply/Service company Eurogentec will acquire proteomics company AnaSpec for an undisclosed sum. AnaSpec's marketed products include...
...assays, SensoLyte assays for high throughput screening and drug discovery, and dye-labeled peptides for diagnostics. Eurogentec...
...includes Eurogentec's OliGold custom oligonucleotides. Achelous Partners LLC advised AnaSpec. AnaSpec Inc. , Fremont, Calif. Eurogentec S.A....
BioCentury | May 14, 2007
Company News

CytoGenix, Eurogentec deal

...CYGX and Eurogentec signed a letter of intent to develop undisclosed products using CYGX's synDNA production...
...influenza, HIV/AIDS, smallpox and HBV. Further terms were not disclosed. CytoGenix Inc. (CYGX), Houston, Texas Eurogentec S.A....
BioCentury | Jan 22, 2007
Company News

Eurogentec, Geymonat S.p.A., Roche, ThromboGenics N.V cardiovascular news

...granted E2 million ($2.6 million) to the Vasoplus research consortium, which consists of THR, Geymonat, Eurogentec...
...is a homolog of vascular endothelial growth factor (VEGF) and is currently in preclinical testing. Eurogentec S.A....
BioCentury | May 1, 2006
Company News

Eurogentec, Oxford Gene Technology Ltd. deal

...Oxford granted Eurogentec a license to Southern array patents, which cover the manufacture, use and marketing...
...which cover the manufacture, use and marketing of oligonucleotide microarrays. Further terms were not disclosed. Eurogentec S.A....
BioCentury | Jul 18, 2005
Company News

Alnylam, Eurogentec deal

...ALNY granted Eurogentec a non-exclusive license to its RNAi patents, for use in developing research products...
...and their use to mediate RNAi in mammalian cells. Alnylam Pharmaceuticals Inc. (ALNY), Cambridge, Mass. Eurogentec S.A....
BioCentury | Apr 11, 2005
Company News

Eurogentec, Proteo Biotech deal

...and proteinase 3. The compound has completed preclinical testing to treat tissue and muscle damage. Eurogentec S.A....
BioCentury | Dec 6, 2004
Company News

Eurogentec SA, SuperArray Bioscience Corp. sales and marketing update

...deal for its first-generation technology will let it focus on its next-generation Oligo GEArray technology. Eurogentec...
BioCentury | Jun 2, 2003
Company News

Epoch Biosciences, Eurogentec deal

...on its MGB Eclipse Probe System business. Also, the companies expanded a 2002 deal for Eurogentec...
...and Japan. As expanded, the deal includes North America. Epoch Biosciences Inc. (EBIO), Bothell, Wash Eurogentec S.A....
Items per page:
1 - 10 of 21